Table 3.
Segmentation performance of hepatic vein (HV) and portal vein (PV) compared with literature
| First Author/ Year | Modality | Segmentation Methodology | Test Dataset Size | Liver Diseases | DSC in test Dataset (HV/PV) | Vessels |
|---|---|---|---|---|---|---|
| Tong/2023 < 15 > | CT | CM U-Net | 80 | NA | 0.70/NA | Only HV |
| Tong/2023 < 17 > | CT | SDA U-Net | 80 | Liver tumors and calcification | 0.71/NA | Only HV |
| Zbinden/2022 < 28 > | MR | 3D nnU-Net | 30 | With/without chronic liver disease | 0.532 /0.634 | HV/PV |
| Oh/2023 < 24 > | MR | 3D Residual U-Net | 12 | Liver tumors | 0.70/0.61 | HV/PV |
| Proposed | CT | 3D U-Net | 178 | Healthy livers, hepatic steatosis, cirrhosis and candidates for major hepatectomy | 0.67/0.68 | HV/PV |